SpaceX at $135: Why You Should Buy SpaceX Ahead of the Planned Starship “Explosion”

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • SPCX crashed 30% to its $135 IPO price while 11 analysts hold a $242 consensus target, implying 79% upside.

  • Prediction markets assign an 89% explosion probability to Starship Flight Test 13, but SpaceX counts planned breakups as engineering progress, not failure.

  • Approximately 200 ETFs now hold SPCX, creating structural buying demand that did not exist when the stock first listed.

  • This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants like General Motors, but only through July 16. (sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
SpaceX at $135: Why You Should Buy SpaceX Ahead of the Planned Starship “Explosion”

© Richard Sagredo / Shutterstock.com

SpaceX (NASDAQ:SPCX | SPCX Price Prediction) trades at $135.27, and the setup ahead of Starship Flight Test 13 is worth examining closely. The stock has round-tripped back to its $135 IPO price after peaking above $225, and the pullback collides with a developmental launch that prediction markets are already treating as a fireball.

SPCX gives public-market investors direct exposure to Elon Musk’s launch, Starlink, and defense franchise. The business dominates U.S. orbital launch cadence, anchors the Space Force’s National Security Space Launch Phase 3 awards, and operates a satellite broadband network that has become core infrastructure. The stock’s pullback reflects a 29.73% one-month drawdown tied to a global tech rout and rising anxiety about the next Starship test, rather than a fundamental miss.

Why the Discount Is the Opportunity

At current levels, buyers pick up SpaceX at its offering price while the company’s addressable market widens. Analyst consensus sits at $242.22, implying 79.06% upside, with 7 Buy, 3 Hold, and 1 Sell ratings. The spread reflects growing conviction on Starlink monetization and defense contracts.

The bull case runs through iterative design. As Defiance ETFs CIO Sylvia Jablonski put it, “SpaceX is a multi-platform infrastructure company involved in launch, communications, defense, and AI connectivity, with Starlink poised to exceed expectations.” Bloomberg’s Eric Balchunas notes SpaceX is now held by approximately 200 ETFs, a structural bid that did not exist at IPO. Every successful Starship iteration pulls forward the reusability curve that Falcon 9 took roughly seven years to mature.

Why the Fireball Scares the Market

Bears see a company priced for perfection heading into a launch that Polymarket handicaps at an 89% probability of explosion. The chopstick booster catch sits at just 0.65%, and Flight Test 12 resolved with a booster explosion. The Atlantic argued SpaceX’s IPO was driven by capital hunger for the AI race, not fundamentals, tagging the stock with a bearish sentiment score of -0.382899. CNBC flagged that the average post-IPO buyer is nearly underwater, and the one-week decline of 8.79% shows the selling continues.

Why Patience Has a Case

The hold argument is timing. Polymarket assigns a 55.5% probability of SPCX closing above $130 by month-end and only a 36% probability above $140. If the booster disintegrates on camera, retail flows may push shares lower before recovering. Waiting for the post-launch result avoids buying into a headline-driven downdraft.

What the Numbers Say

SPCX trades at $135.27 against an $242.22 consensus target across 11 covering analysts, an implied 79.06% upside. The dislocation shows in recent performance: SPCX is down 29.73% over the past month while the S&P 500 is essentially flat, and down 8.79% in the past week against a 1.26% gain for the index.

Sentiment is bifurcated. Of 14 recent news items, 8 skewed bullish and only 1 bearish, yet the composite sentiment index reads 42.07, neutral. Prediction market crowds have run a 66.7% correct rate on prior SPCX resolutions, with a tendency to underestimate upside.

The Verdict: Front-Run the Panic

At $135, SpaceX is a Buy. The path to appreciation runs through interpretation. A planned termination, hypersonic breakup, or intentional ocean crash counts as an explosion on Polymarket, but on SpaceX’s engineering scorecard it is a data-gathering step toward rapid reusability. When the smoke clears and the next iteration flies weeks later, the 29% drawdown starts to look like a mispriced entry.

The near-term catalyst is the launch itself, with 95% probability of flying by July 31. Medium term, Starlink monetization and awarded launch tranches under the NSSL and Space Development Agency pipelines carry the fundamental story. What invalidates the thesis: a total-loss event that grounds the fleet for quarters, or a Starlink competitor closing the gap on cost per bit.

Purchasing SpaceX at its IPO price the week retail expects a fireball is the sort of positioning that analyst desks typically endorse only after the outcome is known.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

ABT Vol: 31,253,149
JBHT Vol: 2,454,381
ERIE Vol: 418,381
DXCM Vol: 6,635,209
CTAS Vol: 4,224,710

Top Losing Stocks

STX Vol: 6,195,644
GLW Vol: 17,581,404
WDC Vol: 10,502,012
CTRA Vol: 73,319,495
SMCI Vol: 35,302,633